Archive for May, 2015
The Mind of Marc Andreessen – The New Yorker
Saturday, May 23rd, 2015QT:{{”
Andreessen laughed and continued, “They were doomed from the start, because Apple in Cupertino”—in Silicon Valley—“had spent three years building that. I’ve been totally determined to be on the other side of that dynamic by being here, because success in software follows a power-law distribution. It’s not Coke and Pepsi and a bunch of others; it’s winner take all. Second prize is a set of steak knives, and third prize is you’re fired.”
“}}
http://www.newyorker.com/magazine/2015/05/18/tomorrows-advance-man
TOMORROW’S ADVANCE MAN
by Joe Pugliese
It Is, in Fact, Rocket Science – NYTimes.com
Saturday, May 23rd, 2015More Consensus on Coffee’s Benefits Than You Might Think
Saturday, May 23rd, 2015Juxtaposed recently in @nytimes Consensus on Coffee’s Benefits v Caffeine…Poses Deadly Risks
http://www.nytimes.com/2015/05/12/upshot/more-consensus-on-coffees-benefits-than-you-might-think.html http://well.blogs.nytimes.com/2015/05/18/caffeine-powder-poses-deadly-risks-2
Caffeine Powder Poses Deadly Risks
http://well.blogs.nytimes.com/2015/05/18/caffeine-powder-poses-deadly-risks-2/
As A Major Retraction Shows, We’re All Vulnerable To Faked Data
Friday, May 22nd, 2015Major #Retraction Shows…Vulnerab[ility] To Faked Data
http://fivethirtyeight.com/datalab/as-a-major-retraction-shows-were-all-vulnerable-to-faked-data Highlights tension betw private data & #reproducibleresearch
32 Avenue of the Americas – Wikipedia, the free encyclopedia
Friday, May 22nd, 2015NYC internet exchange, direct route under the basement to
transatlantic cable, next stop is Telehouse in London
ALK Mutations Confer Differential Oncogenic Activation and Sensitivity to ALK Inhibition Therapy in Neuroblastoma: Cancer Cell
Friday, May 22nd, 2015ALK Mutations Confer Differential Oncogenic Activation
http://www.cell.com/cancer-cell/abstract/S1535-6108%2814%2900393-6 MD modeling better assessing #SNV impact than stats, ie sift
ALK Mutations Confer Differential Oncogenic Activation and Sensitivity to ALK Inhibition Therapy in Neuroblastoma
Scott C. Bresler
Daniel A. Weiser
Peter J. Huwe
…
Ravi Radhakrishnan
Mark A. Lemmon
Yaël P. Mossé